Ondansetron (ADial Pharmaceuticals)

N/A

Report date: 2026/03/13 20:02:36

Base Information

Drug NameOndansetron (ADial Pharmaceuticals)
Drug Alias NameAD04AD-04
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsCocaine-Related DisordersAlcoholismHypotension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesSweden +[8
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesUniversity Of Virginia
Active IndicationsAlcoholism
Inactive IndicationsCocaine-Related DisordersHypotension

Other Information

ATC CodeN/A
Related LinksN/A